Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.

about

Mucuna pruriens Protects against MPTP Intoxicated Neuroinflammation in Parkinson's Disease through NF-κB/pAKT Signaling Pathways.Levodopa-Reduced Seed Extract Shows Neuroprotective Effects against Parkinson's Disease in Murine Microglia and Human Neuroblastoma Cells, , and

P2860

Q47222156-D40BEE0B-3A2E-4E9F-AEE9-165E73CDB5DC Q58717291-59EF0193-6BA3-4596-A195-722B8E6F4E5C

P2860

Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.

Item

http://www.wikidata.org/entity/Q38374505

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Mucuna pruriens in Parkinson d ...... , controlled, crossover study.

@en

type

Item

label

Mucuna pruriens in Parkinson d ...... , controlled, crossover study.

@en

prefLabel

Mucuna pruriens in Parkinson d ...... , controlled, crossover study.

@en

P1476

Mucuna pruriens in Parkinson d ...... , controlled, crossover study.

@en

P2093

Emanuele Cereda

http://www.w3.org/2001/XMLSchema#string

Erica Cassani

http://www.w3.org/2001/XMLSchema#string

Janeth Laguna

http://www.w3.org/2001/XMLSchema#string

Manuela Contin

http://www.w3.org/2001/XMLSchema#string

Michela Barichella

http://www.w3.org/2001/XMLSchema#string

Roberto Cilia

http://www.w3.org/2001/XMLSchema#string

P2860

Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study

Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone on the cardiovascular system of patients with parkinson's disease

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa

A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias.

Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa

The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate.

Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase

The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson's disease.

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

P304

432-438

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000004175

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ioannis Isaias

Nicolò G Pozzi

Gianni Pezzoli

P577

2017-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28679598

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

5539737

http://www.w3.org/2001/XMLSchema#string

Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.

about

P2860

P2860

Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932